Economy Measure Code Measure Currency Code Amount (Local) Amount (USD) Source Details
European Central Bank 05 05 - Health and income support EUR
European Central Bank 05A 05A - Health support EUR
European Central Bank 05B 05B - Income support EUR
European Central Bank 05B1 05B1 - Tax and contribution deferrals and policy changes EUR
European Central Bank 05B2 05B2 - Tax and contribution rates reduction EUR
European Central Bank 05B3 05B3 - Subsidies to individuals and households EUR
European Central Bank 05B4 05B4 - Subsidies to businesses EUR
European Central Bank 05B5 05B5 - Indirect income support EUR
European Central Bank 05B6 05B6 - No breakdown (income support) EUR
European Central Bank 05C 05C - No breakdown (health and income support) EUR
European Central Bank 12 12 - Non-Economic Measures EUR
European Central Bank 12A 12A - Measures affecting travel and transport (local and international) EUR
European Central Bank 12B 12B - Measures affecting business and workplace EUR
European Central Bank 12C 12C - Others EUR
European Union 05 05 - Health and income support EUR 16,446,000,000 18,192,477,876
European Union 05A 05A - Health support EUR 11,319,000,000 12,521,017,699 OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); EC. https://www.consilium.europa.eu/en/press/press-releases/2020/09/11/addressing-covid-19-council-approves-6-2-billion-budget-increase-for-2020/ (accessed 12 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1671 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1680 (accessed 21 September 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1416 (accessed 1 August 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1829 (accessed 10 October 2020); EIB. https://www.eib.org/en/press/all/2020-271-covid-19-eib-provides-eur50-million-to-navarre-to-strengthen-its-health-response-to-covid-19 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2041 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2136 (accessed 21 November 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2200 (accessed 28 November 2020); Council of the EU. https://www.consilium.europa.eu/en/press/press-releases/2020/12/07/council-greenlights-temporary-vat-relief-on-covid-19-vaccines-and-test-kits/ (accessed 7 December 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_50 (accessed 15 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_51 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_655 (accessed 18 February 2021).

(i) 13 March 2020, EUR800 million of the EU Solidarity Fund will be available by including a public health crisis within its scope, with a view of mobilizing it if needed for the hardest-hit EU member states; (ii) 19 March 2020, The European Commission (EC) decided to create a European civil protection stockpile of medical equipment (initial budget of EUR50 million, proposed to increase to EUR80 million) with a 90% Commission grant; (iii) 2 April 2020, The EC presented legislative proposals for an Emergency Support Instrument for the healthcare sector, (EUR3 billion) from the EU budget. 11 September 2020, The EC agreed to add EUR6.2 billion to the EU 2020 budget to address the impact of the COVID-19-crisis and to fund inter alia the vaccine strategy. The revised budget increases payments for the Emergency Support Instrument (ESI) by EUR1.09 billion to ensure the development and deployment of a COVID-19 vaccine. The Commission will use this money as a down-payment for pre-ordering vaccine doses. 18 September 2020, EU allocates EUR150 million for the transport of essential medical items through the ESI and entered into a contract with Sanofi-GSK to purchase up to 300 million doses of the Sanofi-GSK vaccine; (iv) EUR63 million, EC secures EU access to Remdesivir (first European treatment authorized for COVID-19); (v) No amount/estimate: 8 October 2020, the EC approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Once the vaccine has proven to be safe and effective against COVID-19, the contract allows EU Member States to purchase vaccines for 200 million people. They will also have the possibility to purchase vaccines for an additional 200 million people; (vi) 13 October 2020, EIB is providing EUR50 million to the Autonomous Community of Navarre, Spain to strengthen its capacity to respond to the COVID-19 health crisis. The EU bank financing will enable the Spanish region to adapt its healthcare infrastructure to meet the additional costs generated by the pandemic; (vii) No amount/estimate: 11 November 2020, In order to step up the fight against the COVID-19 pandemic and future health emergencies, The EC is taking the first steps towards building the European Health Union. The Commission is putting forward a set of proposals to strengthen the EU's health security framework, and to reinforce the crisis preparedness and response role of key EU agencies; (viii) No amount/estimate: 17 November 2020, The EC approves a fifth contract with CureVac for the initial purchase of 225 million doses of potential vaccine; (ix) No amount/estimate: 25 November 2020, The EC approved a sixth contract under the EU Vaccines Strategy, with the pharmaceutical company Moderna. The contract provides for the initial purchase of 80 million doses on behalf of all EU Member States; (x) 7 December 2020: The Council of Europe adopted amendments to the directive on the common system of value added tax (VAT) to allow member states to temporarily exempt COVID-19 vaccines and testing kits, as well as closely related services, from VAT; (xi) 11 January 2021, The EC supports blood services to increase COVID-19 convalescent plasma collection with grants amounting to EUR36 million financed through the ESI; (xii) No amount/estimate: 12 January 2020, The EC concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses; (xiii) No amount/estimate: 17 February 2021, The EC approves second contract with Moderna to ensure up to additional 300 million doses [update].

European Union 05B 05B - Income support EUR 327,000,000 361,725,664
European Union 05B1 05B1 - Tax and contribution deferrals and policy changes EUR
European Union 05B2 05B2 - Tax and contribution rates reduction EUR
European Union 05B3 05B3 - Subsidies to individuals and households EUR 179,000,000 198,008,850 OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020).

Mobilized European Globalisation Adjustment Fund to support dismissed workers and those self-employed (up to EUR179 million available in 2020).

European Union 05B4 05B4 - Subsidies to businesses EUR 148,000,000 163,716,814 OECD. http://www.oecd.org/coronavirus/en/#country-tracker (accessed 15 April 2020); IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 21 May 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1221 (accessed 9 July 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1872 (accessed 15 October 2020); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1007 (accessed 12 June 2020).

(i) No amount/estimate: 19 March 2020, EU Commission intends to allow State aid for struggling businesses and enable Member States to use the full flexibility foreseen under State aid rules. On 8 May 2020, the European Commission adopted a second amendment to extend the scope of the State aid Temporary Framework to recapitalization and subordinated debt measures to further support the economy in the context of the coronavirus outbreak. The amended Temporary Framework will be in place until the end of December 2020, except for recapitalization measures which has an extended period by the end of June 2021. The Commission will assess before these dates if they need to be extended. 29 June 2020, third amendment to the State aid extends Temporary Framework to enable Member States to provide public support under the Temporary Framework to all micro and small companies, even if they were already in financial difficulty on 31 December 2019; 13 October 2020, EC has decided to prolong and extend the scope of the State aid Temporary Framework adopted on 19 March 2020 to support the economy in the context of the coronavirus outbreak. All sections of the Temporary Framework are prolonged for six months until 30 June 2021, and the section to enable recapitalization support is prolonged for three months until 30 September 2021; (ii) 8 June 2020, European Innovation Council (EIC) Accelerator Pilot fund issued grants of EUR148 million to innovative companies.

European Union 05B5 05B5 - Indirect income support EUR
European Union 05B6 05B6 - No breakdown (income support) EUR
European Union 05C 05C - No breakdown (health and income support) EUR 4,800,000,000 5,309,734,513 EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_997 (accessed 12 June 2020); ESF. https://esf.ie/en/covid-19/react-eu/ (accessed 5 September 2020).

(i) June 2020, EUR4.8 billion (in grants from the amended 2020 annual EU budget) for REACT-EU that will provide additional funding for the most important sectors that will be crucial to lay the basis for a sound recovery. This will involve investment to support job maintenance, including through short-time work schemes and support for the self-employed. The funds can also be used to support job creation and youth employment measures, to health care systems and the provision of working capital and investment support for small and medium-sized enterprises. Such support will be available across economic sectors, including for the much-affected tourism and culture sectors. The additional support will also serve to invest in the European Green Deal and digital transition, as an enhancement to the significant investment in those areas that is already taking place through EU cohesion policy.

European Union 12 12 - Non-Economic Measures EUR
European Union 12A 12A - Measures affecting travel and transport (local and international) EUR IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 29 April 2020); Council of the EU. https://www.consilium.europa.eu/en/press/press-releases/2020/10/13/covid-19-council-adopts-a-recommendation-to-coordinate-measures-affecting-free-movement/ (accessed 26 January 2021); EC https://ec.europa.eu/commission/presscorner/detail/en/ip_21_195 (accessed 26 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_194 (accessed 26 January 2021).

(i) Most European countries have taken several containment measures ranging from lockdowns and travel restrictions to school closures and bans on large gatherings. Measures that favor teleworking were also widely implemented. The European Commission presented guidelines for exit strategies and called for a common framework across member states. The criteria include: (i) sustained reduction and stabilization of new cases, (ii) sufficient health system capacity such as adequate hospital beds, pharmaceutical products, and equipment, and (iii) appropriate monitoring capacity to quickly detect and isolate infected individuals as well as to trace contacts. The Commission invited Schengen Member States and Schengen Associated States to extend the temporary restriction on non-essential travel to the EU until 15 June 2020 and presented further guidance on a gradual lifting of border restrictions; (ii) 13 October 2020, The European Council adopts a recommendation to coordinate measures affecting free movement with the region. EU member states have agreed on a common approach to travel measures and developed common criteria for mapping risk (for details, see: https://bit.ly/3ogFom7). The coordinated approach ensures freedom of movement, increases transparency for citizens and businesses and avoids fragmentation and disruption of services. 25 January 2021, In light of the new coronavirus variant, the EC proposes to update the Council recommendation on the agreed color code for the mapping of risk areas and Stricter measures for travelers from higher-risk areas; (iii) 25 January 2021, EC proposes additional safeguards on travel from outside the EU and updated criteria for applying travel restrictions.

European Union 12B 12B - Measures affecting business and workplace EUR IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 29 April 2020).

Most European countries have taken several containment measures ranging from lockdowns and travel restrictions to school closures and bans on large gatherings. Measures that favor teleworking were also widely implemented.

European Union 12C 12C - Others EUR EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2254 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_3 (accessed 5 February 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2466 (accessed 5 February 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_306 (accessed 5 February 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_3 (accessed 5 February 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_2466 (accessed 5 February 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_306 (accessed 5 February 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_143 (accessed 20 January 2021); EC. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_307 (accessed 5 February 2021).

(i) 2 December 2020, To sustainably manage the pandemic over the winter months, the EC adopted “Staying Safe from COVID-19 during Winter" strategy recommending continued vigilance and caution throughout the winter period and into 2021 when the roll out of safe and effective vaccines will take place. Recommended control measures concern physical distancing and limiting social contacts, testing and contact tracing, and safe travel, among others; (ii) Conditional marketing authorizations (CMA) were granted for the COVID-19 vaccines developed by BioNTech and Pfizer (21 December 2020), Valneva (6 January 2021) and AstraZeneca (29 January 2021). These authorizations follow a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) and are endorsed by the Member States [update]; (iii) 19 January 2021, To step up the fight against the pandemic, The EC called on Member States to accelerate the roll-out of vaccination across the EU, continue to apply physical distancing, limit social contacts, fight disinformation, coordinate travel restrictions, ramp up testing, and increase contact tracing and genome sequencing to face up to the risk from new variants of the virus; (iv) 29 January 2021, To ensure timely access to COVID-19 vaccines for all EU citizens and to tackle the current lack of transparency of vaccine exports outside the EU, The EC put in place a measure requiring that such exports are subject to an authorization by Member States [update].

Turkmenistan 05 05 - Health and income support TMT
Turkmenistan 05A 05A - Health support TMT IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 11 November 2020).

(i) No amount/estimate: The Government announced that a bonus salary of 20%, 15%, and 10% will be given to healthcare professionals working in the remote rural facilities, frontline facilities, and other rural facilities, respectively.

Turkmenistan 05B 05B - Income support TMT
Turkmenistan 05B1 05B1 - Tax and contribution deferrals and policy changes TMT
Turkmenistan 05B2 05B2 - Tax and contribution rates reduction TMT
Turkmenistan 05B3 05B3 - Subsidies to individuals and households TMT
Turkmenistan 05B4 05B4 - Subsidies to businesses TMT
Turkmenistan 05B5 05B5 - Indirect income support TMT
Turkmenistan 05B6 05B6 - No breakdown (income support) TMT
Turkmenistan 05C 05C - No breakdown (health and income support) TMT
Turkmenistan 12 12 - Non-Economic Measures TMT
Turkmenistan 12A 12A - Measures affecting travel and transport (local and international) TMT IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 21 January 2021).

(i) The authorities have adopted a wide range of measures to prevent a COVID-19 outbreak in the country, including closure of borders, flight cancellations and rerouting, and mandatory COVID-19 testing for arriving travelers; (ii) The authorities have imposed restrictions on internal movement, closed roads between some provinces, and stopped rail transportation; (iii) Starting from 24 March 2020, only Turkmen freight carriers are allowed to transport cargo in Turkmenistan; (iv) 30 December 2020, restrictions on domestic and international travel were extended until at least 31 January 2021. Further, a requirement was introduced that all outbound travelers have a signed negative COVID-19 test result within the previous 24 hours.

Turkmenistan 12B 12B - Measures affecting business and workplace TMT IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 11 November 2020).

(i) Starting 24 March 2020, all sports events have been cancelled. Gyms and sports clubs have been shut down in Ashgabat.

Turkmenistan 12C 12C - Others TMT IMF. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-COVID-19 (accessed 11 November 2020).

(i) The authorities have stepped up efforts to digitalize government services, expand e-commerce, and facilitate online and phone payments by SMEs and SOEs through banks; (ii) A commission has been set up for the purchase of essential supplies, medicines, construction equipment, etc.; (iii) As of the first week of November 2020, Turkmenistan has been working with UN agencies to develop a third national plan that covers the humanitarian component of the country's measures to combat COVID-19.